Article may be outdated

This article is 7 days old. Some details may have changed since publication.

CNA·2 min read·easy

Sale of unaffected batches of Medicube capsule cream can resume: HSA

N
Ng Hong Siang
Sale of unaffected batches of Medicube capsule cream can resume: HSA
AI Summary

Singapore's Health Sciences Authority has cleared the sale of unaffected batches of Medicube PDRN Pink Collagen Capsule Cream. This follows a recall of specific batches found to contain trace amounts of the banned Sudan IV dye.

Why it matters

Regulatory oversight of cosmetic products is essential for consumer safety, particularly regarding the presence of carcinogenic substances.

Dive DeeperCreate a free account to unlock

Minute amounts of the banned Sudan IV dye were found in two samples of Medicube PDRN Pink Collagen Capsule Cream sold by Venus Beauty.

The Health Sciences Authority said that sales of unaffected batches of Medicube PDRN Pink Collagen Capsule Cream may resume. (Photo: Medicube)

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthbusiness

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in